Lupin launches additional strength of generic Lotrel capsules

06 Jul 2011 Evaluate

Pharma major, Lupin’s subsidiary - Lupin Pharmaceuticals Inc (LPI) has been granted the final approval by the United Food & Drug Administration (USFDA) for the company’s abbreviated drug application (ANDA) for Amlodipine/ Benazepril 5mg/40mg and 10 mg/40 mg capsules. The commercial shipments of the products have commenced.

This approval completes the product line as the company was granted final approval for Amlodipine/Benazepril 2.5 mg/ 10 mg, 5mg/10mg, 5mg/20 mg and 10 mg/20 mg capsules in February 2010.

Lupin’s Amlodipine/ Benazepril capsules are the AB rated generic equivalents of the Novartis Lotrel capsules indicated for the treatment of hypertension. Amlodipine/ Benazepril 5mg/40mg and 10 mg/40 mg capsules had annual sales of approximately $290 million for the twelve months ended March 2011.

Lupin Share Price

2069.95 26.65 (1.30%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.